Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 781 to 795 of 1809 results for nice guidelines

  1. FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndrome (MIB281)

    NICE has developed a medtech innovation briefing (MIB) on FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndrome .

  2. Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment (DG16)

    Evidence-based recommendations on the My5-FU assay for measuring levels of 5-flurouracil (5-FU) in patients having chemotherapy, to help guide changes to the

  3. Percutaneous vertebroplasty (IPG12)

    Evidence-based recommendations on percutaneous vertebroplasty for spinal metastases. This involves injecting a special bone cement into the spine to relieve pain and stabilise the fracture site.

  4. Healthy.io test for home testing of urine albumin to creatinine ratio (MIB221)

    NICE has developed a medtech innovation briefing (MIB) on Healthy.io test for home testing of urine albumin to creatinine ratio .

  5. Committee C members

    evaluation of health care intervention and outcomes in collaboration with NICE at the London School of Economics (LSE) and Political...

  6. Prevention of lung cancer

    The section of the NICEimpact lung cancer report looking at how lung cancer can be prevented.

  7. Evidence summaries: new medicines – Integrated process statement (PMG11)

    Evidence summaries: new medicines – Integrated process statement

  8. CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attack (DG59)

    Evidence-based recommendations on CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attack

  9. NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds (MIB208)

    NICE has developed a medtech innovation briefing (MIB) on NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds .

  10. Achieving and demonstrating compliance with NICE TA and HST guidance

    that commissioners are funding medicines and treatments approved through the NICE Technology Appraisal (TA) or Highly Specialised...

  11. Confidentiality agreement

    may receive Confidential Information in relation to our participation in NICE's consultation process.Confidential Information means all...

  12. Gastro-oesophageal reflux disease and dyspepsia in adults. Patient decision aid on an option grid to help people make decisions about long term heartburn treatment

    aid is to help you make a decision about treatments recommended in NICE's guideline on gastro-oesophageal reflux disease...

  13. Aquilion PRIME CT scanner for imaging coronary artery disease in adults in whom imaging is difficult (MIB53)

    NICE has developed a medtech innovation briefing (MIB) on the Aquilion PRIME CT scanner for imaging coronary artery disease in adults in whom imaging is difficult .

  14. Complicated intra-abdominal infections: ceftolozane/tazobactam (ESNM75)

    Summary of the evidence on ceftolozane/tazobactam for treating complicated intra-abdominal infections to inform local NHS planning and decision-making

  15. Interim methods guide for developing good practice guidance (PMG15)

    Interim methods guide for developing good practice guidance